Kura Oncology
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $1,270 |
Gross Profit | -202 | -234 | 1,056 | |
EBITDA | -59,676 | -50,229 | -48,893 | -42,178 |
EBIT | -59,884 | -50,431 | -49,127 | -42,392 |
Net Income | -54,404 | -50,837 | -49,525 | -42,786 |
Net Change In Cash | 0 | 0 | 0 | 1,270 |
Free Cash Flow | -43,440 | -42,546 | -48,928 | -34,324 |
Cash | 49,480 | 45,183 | 41,506 | 37,318 |
Basic Shares | 86,950 | 86,635 | 83,905 | 77,337 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -849 | -759 | -558 | -194 |
EBITDA | -164,955 | -139,106 | -129,706 | -91,705 |
EBIT | -165,804 | -139,865 | -130,264 | -91,899 |
Net Income | -152,631 | -136,069 | -129,908 | -89,431 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -38,870 | -234,821 | 299,568 | |
Free Cash Flow | -124,992 | -110,688 | -105,698 | -72,001 |
Cash | 37,318 | 51,802 | 90,672 | 325,493 |
Basic Shares | 73,229 | 66,989 | 66,352 | 53,077 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.63 |
2024-06-30 | -$0.59 |
2024-03-31 | -$0.59 |
2023-12-31 | -$0.55 |
